Barrow researchers identify a new approach to detect the early progression of brain tumorsAugust 29, 2008Researchers at Barrow Neurological Institute at St. Joseph's Hospital and Medical Center recently participated in a pilot study with the Montreal Neurological Institute that suggests a certain type of MRI scanning can detect when a patient is failing brain tumor treatment before symptoms appear. The results of the study pave the way for a proactive treatment approach. The study followed patients with recurring malignant brain tumors who were receiving chemotherapy. Patients received scans through an imaging device called MR spectroscopy to identify metabolic changes. The scanning technique suggested that the use of metabolic imaging identifies chemical changes earlier than structural imaging such as a conventional MRI and CT scans. This approach allowed researchers to determine if the tumors were responding to treatment early by assessing metabolic changes in a brain tumor, which are easy to detect and appear before structural changes or symptoms. The result may give patients more time to try another treatment. "The study has shown for the first time that metabolic response to brain tumor treatment can be detected earlier and faster by metabolic imaging instead of through structural imaging or assessment of the neurological status of a patient," says Mark C. Preul, M.D., Newsome Chair of Neurosurgery Research at St. Joseph's.
The imaging can be done often, poses no radiation hazard and is non-invasive. "Frequent use of this type of imaging may be a useful tool to follow a patient's response to chemotherapy for malignant brain tumors," says Dr. Preul. "It gives us the ability to identify treatment failure early and more time to alter a patient's treatment plan before the disease progresses." As a result of the pilot study, Barrow researchers are planning to conduct a second study that will use imaging in the same way to monitor the effects of brain tumor treatment. They are also developing imaging modalities that will show how brain tumors change their shape and metabolism with treatment. St. Joseph's Hospital and Medical Center | |||||||||||||||||||||
|
Related Brain Tumor Current Events and Brain Tumor News Articles New imaging technique tracks cancer-killing cells over prolonged period Coaxing a patient's own cells to hunt down and tackle infected or diseased cells is a promising therapeutic approach for many disorders. Mechanism in cells that generate malignant brain tumors may offer target for gene therapy Researchers at Cedars-Sinai Medical Center's Maxine Dunitz Neurosurgical Institute who first isolated cancer stem cells in adult brain tumors in 2004 have now identified a molecular mechanism that is involved in the development of these cells from which malignant brain tumors may originate. Pediatric study finds alternatives for radiation of low-grade brain tumors A multi-institutional study led by researchers at The University of Texas M. D. Anderson Cancer Center has found that using chemotherapy alone and delaying or avoiding cranial radiation altogether can be effective in treating pediatric patients with unresectable or progressive low-grade glioma. New approach to gene therapy may shrink brain tumors, prevent their spread Massachusetts General Hospital (MGH) researchers are investigating a new approach to gene therapy for brain tumors - delivering a cancer-fighting gene to normal brain tissue around the tumor to keep it from spreading. Family history of brain tumors linked to increased risk of brain cancer People with a family history of cancerous brain tumors appear to be at higher risk of developing the same kind of tumors compared to people with no such family history. Childhood brain tumor traced to normal stem cells gone bad An aggressive childhood brain tumor known as medulloblastoma originates in normal brain "stem" cells that turn malignant when acted on by a known mutant, cancer-causing oncogene, say researchers from Dana-Farber Cancer Institute and the University of California, San Francisco (UCSF). Erectile dysfunction drugs allowed more chemotherapy to reach brain tumors in laboratory study In a study using laboratory animals, researchers found that medications commonly prescribed for erectile dysfunction opened a mechanism called the blood-brain tumor barrier and increased delivery of cancer-fighting drugs to malignant brain tumors. Certain anticancer agents could be harmful to patients with heart disease A set of promising new anticancer agents could have unforeseen risks in individuals with heart disease, suggests research at Washington University School of Medicine in St. Louis. St. Jude finds young age may give survival advantage to children with certain brain tumors St. Jude Children's Research Hospital investigators have shown that children under 3 years old who have a brain tumor called diffuse pontine glioma (DPG) appear to have a better outcome than older children with the same cancer. Brown Chemists Create Cancer-Detecting Nanoparticles A team led by a Brown University chemist has created the smallest iron oxide nanoparticles to date for cancer detection by magnetic resonance imaging (MRI). The magnetic nanoparticles operate like tiny guided missiles, seeking and attaching themselves to malignant tumor cells. Once they bind, the particles emit stronger signals that MRI scans can detect. More Brain Tumor Current Events and Brain Tumor News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||